Madelon Paauwe

1.2k total citations
16 papers, 805 citations indexed

About

Madelon Paauwe is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Madelon Paauwe has authored 16 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Madelon Paauwe's work include Cancer, Hypoxia, and Metabolism (8 papers), TGF-β signaling in diseases (7 papers) and Angiogenesis and VEGF in Cancer (3 papers). Madelon Paauwe is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), TGF-β signaling in diseases (7 papers) and Angiogenesis and VEGF in Cancer (3 papers). Madelon Paauwe collaborates with scholars based in Netherlands, United States and United Kingdom. Madelon Paauwe's co-authors include Lukas J.A.C. Hawinkels, Peter ten Dijke, Cornelis F.M. Sier, Eliza Wiercinska, Wilma E. Mesker, J. Lindeman, Hein W. Verspaget, Kattria van der Ploeg, Pim J. Koelink and James C.H. Hardwick and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Madelon Paauwe

15 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madelon Paauwe Netherlands 13 456 380 261 131 114 16 805
Femke Hillen Netherlands 8 531 1.2× 349 0.9× 321 1.2× 154 1.2× 114 1.0× 9 882
Carolina Zandueta Spain 17 443 1.0× 305 0.8× 281 1.1× 119 0.9× 168 1.5× 25 833
Yanhua Xuan China 18 539 1.2× 381 1.0× 221 0.8× 111 0.8× 115 1.0× 47 884
Arild Holth Norway 20 512 1.1× 373 1.0× 303 1.2× 180 1.4× 175 1.5× 54 1.1k
Martin Boettcher Germany 5 466 1.0× 428 1.1× 314 1.2× 91 0.7× 109 1.0× 6 793
Nadia Coltella Italy 16 387 0.8× 194 0.5× 206 0.8× 109 0.8× 114 1.0× 24 709
Xiang Peng China 13 594 1.3× 453 1.2× 308 1.2× 72 0.5× 177 1.6× 22 986
Matteo Bocci Sweden 9 430 0.9× 458 1.2× 229 0.9× 184 1.4× 95 0.8× 14 804
Michael Bartoschek Sweden 9 499 1.1× 498 1.3× 280 1.1× 234 1.8× 112 1.0× 11 898

Countries citing papers authored by Madelon Paauwe

Since Specialization
Citations

This map shows the geographic impact of Madelon Paauwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madelon Paauwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madelon Paauwe more than expected).

Fields of papers citing papers by Madelon Paauwe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madelon Paauwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madelon Paauwe. The network helps show where Madelon Paauwe may publish in the future.

Co-authorship network of co-authors of Madelon Paauwe

This figure shows the co-authorship network connecting the top 25 collaborators of Madelon Paauwe. A scholar is included among the top collaborators of Madelon Paauwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madelon Paauwe. Madelon Paauwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dandamudi, Durga Bhavani, Iwona Konieczna, Paul A. Ellis, et al.. (2025). Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma. Leukemia & lymphoma. 66(9). 1688–1699.
2.
Sacchetti, Andrea, Miriam Teeuwssen, Rosalie Joosten, et al.. (2021). Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. eLife. 10. 43 indexed citations
3.
Schoonderwoerd, Mark J.A., et al.. (2021). Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model. OncoTargets and Therapy. Volume 14. 5205–5220. 7 indexed citations
4.
Schoonderwoerd, Mark J.A., Madelon Paauwe, Marieke C. Barnhoorn, et al.. (2020). Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy. Clinical Cancer Research. 26(14). 3831–3842. 37 indexed citations
5.
Voorneveld, Philip W., Eveline S. M. de Jonge‐Muller, Mark J.A. Schoonderwoerd, et al.. (2020). Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer. Oncogene. 39(12). 2453–2466. 20 indexed citations
6.
Liu, Yingmiao, Madelon Paauwe, Andrew B. Nixon, & Lukas J.A.C. Hawinkels. (2020). Endoglin Targeting: Lessons Learned and Questions That Remain. International Journal of Molecular Sciences. 22(1). 147–147. 23 indexed citations
7.
Kaymak, Irem, Werner Schmitz, Andrew D. Campbell, et al.. (2019). Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress. Cancer Research. 80(2). 189–203. 66 indexed citations
8.
Paauwe, Madelon, Mark J.A. Schoonderwoerd, Roxan F.C.P. Helderman, et al.. (2018). Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Clinical Cancer Research. 24(24). 6331–6344. 132 indexed citations
9.
Paauwe, Madelon, Gabi W. van Pelt, Chao Cui, et al.. (2016). Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. Oncogene. 35(31). 4069–4079. 56 indexed citations
10.
Hawinkels, Lukas J.A.C., Amaya García de Vinuesa, Madelon Paauwe, et al.. (2015). Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors. Clinical Cancer Research. 22(1). 96–106. 45 indexed citations
11.
Hawinkels, Lukas J.A.C., Amaya García de Vinuesa, Madelon Paauwe, et al.. (2015). Abstract 1370: Activin receptor-like kinase 1 ligand trap reduces microvascular density and improves chemotherapy efficiency to various solid tumors. Cancer Research. 75(15_Supplement). 1370–1370. 1 indexed citations
12.
Hawinkels, Lukas J.A.C., Luuk te Riet, Madelon Paauwe, et al.. (2015). Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels. Scientific Reports. 5(1). 16872–16872. 21 indexed citations
13.
Rooswinkel, Rogier W., Bert van de Kooij, Evert de Vries, et al.. (2014). Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood. 123(18). 2806–2815. 83 indexed citations
14.
Kooij, Bert van de, Rogier W. Rooswinkel, Evert de Vries, et al.. (2013). Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B. Oncogene. 32(48). 5439–5448. 18 indexed citations
15.
Paauwe, Madelon, Peter ten Dijke, & Lukas J.A.C. Hawinkels. (2013). Endoglin for tumor imaging and targeted cancer therapy. Expert Opinion on Therapeutic Targets. 17(4). 421–435. 36 indexed citations
16.
Hawinkels, Lukas J.A.C., Madelon Paauwe, Hein W. Verspaget, et al.. (2012). Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts. Oncogene. 33(1). 97–107. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026